Johnson Pharmacare auditor issues going concern warning
The statutory auditor flagged a cash loss of ₹11,123.52 lakhs, dwarfing the company's ₹30 crore market cap.
— 2 earlier stories on Johnson Pharmacare Ltd. →What's new
- Auditor issued a qualified opinion and a going concern warning.
- Company reported a cash loss of ₹11,123.52 lakhs against a ₹30 crore market cap.
- Auditor flagged non-compliance with Ind AS and potential NBFC registration requirements.
Why this matters
The company has zero operational revenue and is now facing a formal going concern warning. With liabilities exceeding assets and internal control failures, the firm faces an immediate solvency crisis.
What we're watching
- Potential regulatory intervention from the RBI regarding NBFC status.
- Any attempt by the company to address the qualified audit opinion.
- The company's ability to service its ₹2,140.04 lakhs in debt.
The full read
Johnson Pharmacare has received a scathing audit report for the fiscal year ended March 31, 2026. The statutory auditor issued a qualified opinion and a formal going concern warning, citing the company's inability to meet liabilities due within the next year. The firm reported an annual cash loss of ₹11,123.52 lakhs, a figure that dwarfs its ₹30 crore market capitalization. With zero operational revenue, the company's financial position is precarious. The auditor identified significant deficiencies in internal controls, non-compliance with Indian Accounting Standards, and investments in unquoted instruments with opaque valuations. The auditor also noted the company may be required to register under RBI regulations as an NBFC. Given the ₹2,140.04 lakhs in outstanding loans and the lack of revenue, the audit report signals a severe solvency risk that leaves little room for recovery.
Questions answered
- What is the primary concern raised by the auditor?
- The auditor issued a going concern warning, stating the company appears unable to meet its liabilities as they fall due within a year.
- How does the reported cash loss compare to the company's size?
- The company reported a cash loss of ₹11,123.52 lakhs, which is significantly larger than its market capitalization of approximately ₹30 crores.
- Are there other compliance issues mentioned?
- The auditor flagged non-adherence to Indian Accounting Standards, deficiencies in internal controls, and the possibility that the firm must register as an NBFC.
- Does the company have any debt?
- The balance sheet shows borrowed loans totaling ₹2,140.04 lakhs.
Story so far
All notes on JOHNPHARMA →- 27 May 2026 · 7:55 PM IST Johnson Pharmacare auditor issues going concern warning
- today Johnson Pharmacare reports zero revenue and a massive annual loss.
- today Johnson Pharmacare auditor warns of insolvency risk